Guía de prevención y tratamiento de la osteoporosis inducida por glucocorticoides de la Sociedad Española de Medicina Interna

Henríquez, M. Sosa; Curiel, Manuel Dı́az; Pérez, Adolfo Díez; Alonso, Carlos Gómez; Macías, J. González; Minguella, J. Farrerons; Rubio, J. Filgueira; Saidler, Leonardo Mellibovsky; Solán, X. Nogués; Hernández, Daniel

doi:10.1157/13115006

Cited by 14 publications

(7 citation statements)

References 96 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Special emphasis should be placed on medication adjustment and control of underlying diseases as they increase the presence of osteoporosis and falls, causing an increased risk of hip fracture [61][62][63][64]. These are as psychoactive drugs (hypnotics, anxiolytics, antidepressants, antiepileptics, benzodiazepines, opioids, etc.…”

Section: Discussionmentioning

confidence: 99%

“…Drugs responsible for falls increase in older people: o Psychoactives: hypnotics, anxiolytics, antidepressants, antiepileptics, benzodiazepines, opioids, etc. [59,60] o Drugs at risk of postural hypotension: diuretics, antihypertensives [61][62][63][64]. Medication that can cause postural hypotension, foot problems and the use of appropriate footwear should also be evaluated [43,65,66].…”

Section: Medicationmentioning

confidence: 99%

See 1 more Smart Citation

Non-Pharmacological Interventions towards Preventing the Triad Osteoporosis-Falls Risk-Hip Fracture, in Population Older than 65. Scoping Review

Peraza-Delgado

Gómez

Gómez‐Salgado

et al. 2020

JCM

View full text Add to dashboard Cite

Osteoporosis leads to increased risk of falls, and thus an increase in fractures, highlighting here hip fractures, that result in high mortality, functional disability, and high medical expenditure. The aim is to summarise the available evidence on effective non-pharmacological interventions to prevent the triad osteoporosis/falls risk/hip fracture. A scoping review was conducted consulting the Scientific Electronic Library Online (Scielo), National Institute for Health and Care Excellence (NICE), Cumulative Index to Nursing & Allied Health Literature (CINAHL) y PubMed.databases. Inclusion criteria were articles published between 2013 and 2019, in Spanish or English. In addition, publications on a population over 65 years of age covering non-pharmacological interventions aimed at hip fracture prevention for both institutionalised patients in long-stay health centres or hospitals, and patients cared for at home, both dependent and non-dependent, were included. Sixty-six articles were selected and 13 non-pharmacological interventions were identified according to the Nursing Interventions Classification taxonomy, aimed at preventing osteoporosis, falls, and hip fracture. The figures regarding the affected population according to the studies are alarming, reflecting the importance of preventing the triad osteoporosis, falls risk, and hip fracture among the population over 65 years of age. The most effective interventions were focused on increasing Bone Mineral Density through diet, exercise, and falls prevention. As a conclusion, primary prevention should be applied to the entire adult population, with special emphasis on people with osteoporosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Medicationmentioning

confidence: 99%

Non-Pharmacological Interventions towards Preventing the Triad Osteoporosis-Falls Risk-Hip Fracture, in Population Older than 65. Scoping Review

Peraza-Delgado

Gómez

Gómez‐Salgado

et al. 2020

JCM

View full text Add to dashboard Cite

show abstract

“…Thus, slightly less than half of the patients with criteria for the prophylaxis of osteoporosis by corticoids were taking bisphosphonates, a similar figure to that reported in a North American study 10 . The guide of the Spanish Society of Internal Medicine recommends prophylactic treatment for corticoidinduced osteoporosis in postmenopausal women if they are going to receive, or are receiving, >5 mg/day of prednisone or equivalent for more than 3 months 6 . On their part, the consensus of the Spanish Rheumatology Society advises preventative measures in those patients who are going to take doses equivalent to ≥5 mg/day of prednisone for more than 3 months, reserving pharmacological treatment for those patients with a risk factor 4 .…”

Section: Discussionmentioning

confidence: 99%

“…In addition to the classic risk factors, the disease itself and the use of corticoids are considered as independent factors for the risk of fracture, as is outlined in the FRAX ® tool 3 . In the clinical monitoring of the patient with RA, the rheumatologist takes into account the guides to the management of OP 4,5 , as well as the guides to the prevention of corticoid-induced osteoporosis 6,7 . This study analyses the use of bisphosphonates in postmenopausal women with RA in clinical practice.…”

Section: Introductionmentioning

confidence: 99%

Empleo de bisfosfonatos en mujeres postmenopáusicas con artritis reumatoide: resultados de un estudio multicéntrico

Ojeda

Talaverano

Nóvoa-Medina

et al. 2015

Rev Osteoporos Metab Miner

View full text Add to dashboard Cite

SummaryObjective: The objective of this study was to analyse the use of bisphosphonates in women with rheumatoid arthritis (RA) in the Canary Islands. Material and methods: This multicentre observational study included women aged 50 years or over. At a single visit, demographic variables and those relating to the RA, history of fragility fractures, use of corticoids, performance of bone densitometry (DXA) and current treatment with bisphosphonates were recorded. The simplified FRAX ® tool was used and the recommendations of the American College of Rheumatology (ACR) for the prophylaxis of osteoporosis with corticoids were applied. Results: 192 women were included, with an average age of 62 years. A total of 91 (48%) patients were receiving corticoids; 17 of these (9%) had suffered a fracture; 123 (66%) had had a DXA; and 52 (28%) were taking bisphosphonates (70% of the patients with osteoporosis or fracture and 45% of those with criteria for prophylactic use of corticoids for osteoporosis). Those factors having a significant association with the use of bisphosphonates were age, duration of the disease, the HAQ functional capacity questionnaire, the risk of fracture determined by FRAX ® , treatment with corticoids, history of fracture and the previous performance of DXA. In the multivariate study only the DXA (p=0.03) and history of fracture (p=0.02) were significantly associated. Conclusions: In postmenopausal women from the Canary Islands with RA the prescription of bisphosphonates could conform better to the guidelines, especially in patients receiving treatment with corticoids.

show abstract

“…En la OIC el tratamiento aceptado en la actualidad, con evidencia científica, incluye los bisfosfonatos, el calcio y la vitamina D, y la teriparatida, que se utilizará en casos graves. [160][161][162][163][164][165][166][167][168][169][170][171] .…”

Section: 8) Tratamientounclassified

Valoración de la influencia de diversos factores de riesgo de osteoporosis en mujeres con artritis reumatoide, tratadas con glucocorticoides

Ferreras¹

View full text Add to dashboard Cite

Guía de prevención y tratamiento de la osteoporosis inducida por glucocorticoides de la Sociedad Española de Medicina Interna

Cited by 14 publications

References 96 publications

Non-Pharmacological Interventions towards Preventing the Triad Osteoporosis-Falls Risk-Hip Fracture, in Population Older than 65. Scoping Review

Non-Pharmacological Interventions towards Preventing the Triad Osteoporosis-Falls Risk-Hip Fracture, in Population Older than 65. Scoping Review

Empleo de bisfosfonatos en mujeres postmenopáusicas con artritis reumatoide: resultados de un estudio multicéntrico

Valoración de la influencia de diversos factores de riesgo de osteoporosis en mujeres con artritis reumatoide, tratadas con glucocorticoides

Contact Info

Product

Resources

About